Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients

Selinger, CP; Parkes, GC; Bassi, A; Limdi, JK; Ludlow, H; Patel, P; Smith, M; Saluke, S; Ndlovu, Z; George, B; Saunders, J; Adamson, M; Fraser, A; Robinson, J; Donovan, F; Parisi, I; Tidbury, J; Gray, L; Pollok, R; Scott, G; Raine, T

Selinger, CP (reprint author), Leeds Teaching Hosp NHS Trust, St James Univ Hosp, Leeds Gastroenterol Inst, Bexley Wing, Leeds LS9 7TF, W Yorkshire, England.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019; 50 (9): 1009

Abstract

Background Patients with IBD are at risk of excess corticosteroids. Aims To assess steroid excess in a large IBD cohort and test associations with qua......

Full Text Link